Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/5/2025

Rizatriptan Dosing Considerations for Migraine

Cardiovascular Disease Considerations

  • The American Academy of Family Physicians recommends that rizatriptan is contraindicated in patients with ischemic vascular conditions, vasospastic coronary disease, uncontrolled hypertension, or other significant cardiovascular disease 1, 2
  • Triptans can cause coronary vasospasm and should not be used in patients with coronary artery disease (CAD), according to the American Family Physician 1
  • Alternative agents such as gepants (ubrogepant, rimegepant) should be considered for patients with cardiovascular contraindications, as suggested by the Praxis Medical Insights 3

Medication Overuse Headache Prevention

  • The Praxis Medical Insights recommends limiting rizatriptan use to no more than 2 days per week to prevent medication-overuse headache, and not treating more than 4 headaches per 30-day period on average 3
  • Medication-overuse headache can result from frequent use of acute medications (more than twice weekly), leading to increasing headache frequency and potentially daily headaches, according to the Praxis Medical Insights 3
  • If patients require acute treatment more than twice weekly, preventive therapy should be initiated immediately, as recommended by the Praxis Medical Insights 3

REFERENCES

1

management of the acute migraine headache. [LINK]

American family physician, 2002

2

Triptans and Sensory Disturbances [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Acute Headache Treatment Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026